QSM在神经退行性疾病中的应用进展

侯 鹏飞, 韩 雪, 王 红*
新疆医科大学第二附属医院影像中心 乌鲁木齐 830063

摘要

摘要：神经退行性疾病(neurodegenerative disease)是神经元结构及功能进行性丧失为主要特点的异质性疾病，包括阿尔茨海默病(Alzheimer'sdisease，AD)、帕金森病(Parkinson'sdisease，PD)、肌萎缩侧索硬化症(Amyotrophic lateral sclerosis，ALS)、亨廷顿病（Huntington'sdisease，HD）、额颞叶痴呆(Fronto temporal dementia，FTD)、威尔逊病（Wilson'sdisease，WD）。定量磁敏感成像（Quantitative susceptibility mapping，QSM）成像是近年来发展起来的磁共振成像技术，通过测量脑内组织铁含量，反映组织细胞的生理及病理信息。本文旨在阐述QSM技术优势，综述其在神经退行性相关疾病中的研究现状。

关键词

关键词：定量磁敏感成像、神经退行性疾病

参考

[1]Sun, Y., et al., Mechanisms of Ferroptosis and Emerging Links to thePathology of Neurodegenerative Diseases. Front Aging Neurosci, 2022. 14: p.904152.[2]Haller, S., et al., Susceptibility-weighted Imaging: TechnicalEssentials and Clinical Neurologic Applications. Radiology, 2021. 299(1): p.3-26.[3]杨奡偲, 阿尔兹海默症患者全脑铁沉积与脑结构改变的MRI研究,2021, 山东大学. 第 71页.[4]Hwang, E.J., et al., Texture analyses of quantitative susceptibilitymaps to differentiate Alzheimer's disease from cognitive normal and mildcognitive impairment. Med Phys, 2016. 43(8): p. 4718.[5]Du L, et al., Increased Iron Deposition on Brain QuantitativeSusceptibility Mapping Correlates with Decreased Cognitive Function inAlzheimer's Disease. ACS Chem Neurosci, 2018. 9(7): p. 1849-1857.[6]van Bergen, J.M., et al., Colocalization of cerebral iron with Amyloidbeta in Mild Cognitive Impairment. Sci Rep, 2016. 6: p. 35514.[7]Tiepolt, S., et al., Quantitative Susceptibility Mapping of Amyloid-betaAggregates in Alzheimer's Disease with 7T MR. J Alzheimers Dis, 2018.64(2): p. 393-404.[8]Murakami, Y., et al., Usefulness of quantitative susceptibility mappingfor the diagnosis of Parkinson disease. AJNR Am J Neuroradiol, 2015. 36(6):p. 1102-8.[9]Du G, et al., Quantitative susceptibility mapping of the midbrain inParkinson's disease. Mov Disord, 2016. 31(3): p. 317-24.[10]Uchida, Y., et al., Magnetic Susceptibility Associates WithDopaminergic Deficits and Cognition in Parkinson's Disease. Mov Disord,2020. 35(8): p. 1396-1405.[11]Nikparast, F., Z. Ganji and H. Zare, Early differentiation ofneurodegenerative diseases using the novel QSM technique: what is thebiomarker of each disorder? BMC Neurosci, 2022. 23(1): p. 48.[12]He, N., et al., Dentate nucleus iron deposition is a potentialbiomarker for tremor-dominant Parkinson's disease. NMR Biomed, 2017.30(4).[13]Eskreis-Winkler, S., et al., The clinical utility of QSM: diseasediagnosis, medical management, and surgical planning. NMR Biomed, 2017.30(4).[14]Acosta-Cabronero, J., et al., Quantitative Susceptibility MRI toDetect Brain Iron in Amyotrophic Lateral Sclerosis. Radiology, 2018. 289(1):p. 195-203.[15]Schweitzer, A.D., et al., Quantitative susceptibility mapping of themotor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis.AJR Am J Roentgenol, 2015. 204(5): p. 1086-92.[16]van Bergen, J.M., et al., Quantitative Susceptibility Mapping SuggestsAltered Brain Iron in Premanifest Huntington Disease. AJNR Am JNeuroradiol, 2016. 37(5): p. 789-96.[17]Chen, L., et al., Altered brain iron content and deposition rate inHuntington's disease as indicated by quantitative susceptibility MRI. JNeurosci Res, 2019. 97(4): p. 467-479.[18]van Bergen, J.M., et al., Quantitative Susceptibility Mapping SuggestsAltered Brain Iron in Premanifest Huntington Disease. AJNR Am JNeuroradiol, 2016. 37(5): p. 789-96.[19]Sheelakumari, R., et al., Assessment of Iron Deposition in the Brainin Frontotemporal Dementia and Its Correlation with Behavioral Traits.AJNR Am J Neuroradiol, 2017. 38(10): p. 1953-1958.[20]刘海燕与赵超蓉, 血管性痴呆的中西医研究进展. 现代中西医结合杂志, 2021. 30(03): 第334-338页.[21]Fritzsch, D., et al., Seven-tesla magnetic resonance imaging inWilson disease using quantitative susceptibility mapping for measurement ofcopper accumulation. Invest Radiol, 2014. 49(5): p. 299-306.[22]Doganay, S., et al., Magnetic Susceptibility Changes in the BasalGanglia and Brain Stem of Patients with Wilson's Disease: Evaluation withQuantitative Susceptibility Mapping. Magn Reson Med Sci, 2018. 17(1): p.73-79.